Position in LLY
as of Mar 31, 2026
· filed May 21, 2026
Position Value
$121,571,518
-$24,307,707 QoQ
Shares Held
132,176
-2.6% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
1.73%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 97.10083524996975.ToString("F0")%
Shared 0.ToString("F0")%
None 2.8991647500302626.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Groupe la Francaise holds $378,895,176 across 11 Drug Manufacturers - General names. LLY ranks #2 (32.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
984,608 | $194,184,389 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
132,176 | $121,571,518 | |
| 3 | ABBV |
AbbVie Inc.
|
193,380 | $42,058,216 | |
| 4 | MRK |
Merck & Co., Inc.
|
73,551 | $8,847,449 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
37,915 | $5,284,213 | |
| 6 | JNJ |
Johnson & Johnson
|
18,204 | $4,449,784 | |
| 7 | GRFS |
Grifols SA
|
238,928 | $1,916,202 | |
| 8 | PFE |
Pfizer Inc
|
18,173 | $510,297 |
All Filings in LLY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $121,571,518 | 132,176 | Shares | Defined | 2026-05-21 | |
| 2025-12-31 | $145,879,225 | 135,742 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $140,835,303 | 184,581 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $140,947,598 | 180,811 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $89,593,889 | 108,479 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $85,984,588 | 111,379 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||